Analysis of biopsy-diagnosed samples may also clarify whether, like HSD17B13 [16,17], MARC1 has differing associations with fatty liver, non-alcoholic steatohepatitis and cirrhosis. Here, MTARC1 is linked to metabolic dysfunction-associated steatohepatitis.